153 related articles for article (PubMed ID: 27695439)
41. Current data on ATP-containing liposomes and potential prospects to enhance cellular energy status for hepatic applications.
Korb V; Tep K; Escriou V; Richard C; Scherman D; Cynober L; Chaumeil J; Dumortier G
Crit Rev Ther Drug Carrier Syst; 2008; 25(4):305-45. PubMed ID: 18540841
[TBL] [Abstract][Full Text] [Related]
42. Sirolimus encapsulated liposomes for cancer therapy: physicochemical and mechanical characterization of sirolimus distribution within liposome bilayers.
Onyesom I; Lamprou DA; Sygellou L; Owusu-Ware SK; Antonijevic M; Chowdhry BZ; Douroumis D
Mol Pharm; 2013 Nov; 10(11):4281-93. PubMed ID: 24099044
[TBL] [Abstract][Full Text] [Related]
43. Engineered liposomes bearing camptothecin analogue for tumour targeting:
Saraf S; Jain A; Tiwari A; Verma A; Jain SK
J Liposome Res; 2021 Dec; 31(4):326-341. PubMed ID: 32718195
[TBL] [Abstract][Full Text] [Related]
44. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP
Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682
[TBL] [Abstract][Full Text] [Related]
45. Preclinical study of Doxorubicine-loaded liposomal drug delivery for the treatment of head and neck cancer: Optimization by Box-Behnken statistical design.
Yang B
Acta Biochim Pol; 2020 Jun; 67(2):149-155. PubMed ID: 32506868
[TBL] [Abstract][Full Text] [Related]
46. pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment.
Nunes SS; Miranda SEM; de Oliveira Silva J; Fernandes RS; de Alcântara Lemos J; de Aguiar Ferreira C; Townsend DM; Cassali GD; Oliveira MC; Branco de Barros AL
Biomed Pharmacother; 2021 Dec; 144():112317. PubMed ID: 34634556
[TBL] [Abstract][Full Text] [Related]
47. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
48. Polymyxin E sulfate-loaded liposome for intravenous use: preparation, lyophilization, and toxicity assessment in vivo.
Wang D; Kong L; Wang J; He X; Li X; Xiao Y
PDA J Pharm Sci Technol; 2009; 63(2):159-67. PubMed ID: 19634354
[TBL] [Abstract][Full Text] [Related]
49. Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity.
Leite EA; Souza CM; Carvalho-Júnior AD; Coelho LG; Lana AM; Cassali GD; Oliveira MC
Int J Nanomedicine; 2012; 7():5259-69. PubMed ID: 23091378
[TBL] [Abstract][Full Text] [Related]
50. Surfactant Assisted Rapid-Release Liposomal Strategies Enhance the Antitumor Efficiency of Bufalin Derivative and Reduce Cardiotoxicity.
Gao L; Zhang L; He F; Chen J; Zhao M; Li S; Wu H; Liu Y; Zhang Y; Ping Q; Hu L; Qiao H
Int J Nanomedicine; 2021; 16():3581-3598. PubMed ID: 34079251
[TBL] [Abstract][Full Text] [Related]
51. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
[TBL] [Abstract][Full Text] [Related]
52. Nanoparticles for the delivery of zoledronic acid to prostate cancer cells: a comparative analysis through time lapse video-microscopy technique.
Schiraldi C; Zappavigna S; D' Agostino A; Porto S; Gaito O; Lusa S; Lamberti M; De Rosa M; De Rosa G; Caraglia M
Cancer Biol Ther; 2014; 15(11):1524-32. PubMed ID: 25482949
[TBL] [Abstract][Full Text] [Related]
53. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue.
Wu NZ; Da D; Rudoll TL; Needham D; Whorton AR; Dewhirst MW
Cancer Res; 1993 Aug; 53(16):3765-70. PubMed ID: 8339289
[TBL] [Abstract][Full Text] [Related]
54. Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes.
Zhai B; Wu Q; Wang W; Zhang M; Han X; Li Q; Chen P; Chen X; Huang X; Li G; Zhang Q; Zhang R; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Cancer Biol Med; 2020 Feb; 17(1):60-75. PubMed ID: 32296587
[No Abstract] [Full Text] [Related]
55. Preparation of Barije (Ferula gummosa) Essential Oil-Loaded Liposomes and Evaluation of Physical and Antibacterial Effect on Escherichia coli O157:H7.
Najaf Najafi M; Arianmehr A; Sani AM
J Food Prot; 2020 Mar; 83(3):511-517. PubMed ID: 32073614
[TBL] [Abstract][Full Text] [Related]
56. Pegylated liposomal encapsulation improves the antitumor efficacy of combretastatin A4 in murine 4T1 triple-negative breast cancer model.
Mirzavi F; Barati M; Vakili-Ghartavol R; Roshan MK; Mashreghi M; Soukhtanloo M; Jaafari MR
Int J Pharm; 2022 Feb; 613():121396. PubMed ID: 34942328
[TBL] [Abstract][Full Text] [Related]
57. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
58. The shape/morphology balance: a study of stealth liposomes via fractal analysis and drug encapsulation.
Pippa N; Psarommati F; Pispas S; Demetzos C
Pharm Res; 2013 Sep; 30(9):2385-95. PubMed ID: 23743657
[TBL] [Abstract][Full Text] [Related]
59. Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release.
Luo D; Carter KA; Razi A; Geng J; Shao S; Giraldo D; Sunar U; Ortega J; Lovell JF
Biomaterials; 2016 Jan; 75():193-202. PubMed ID: 26513413
[TBL] [Abstract][Full Text] [Related]
60. Preparation, characterization and tissue distribution of brucine stealth liposomes with different lipid composition.
Li J; Chen J; Cai BC; Yang T
Pharm Dev Technol; 2013; 18(4):772-8. PubMed ID: 21780866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
